Jeffrey M Judis, MD | |
5700 Monroe St, Suite 202, Sylvania, OH 43560-2767 | |
(419) 473-6622 | |
(419) 473-6627 |
Full Name | Jeffrey M Judis |
---|---|
Gender | Male |
Speciality | Obstetrics/gynecology |
Experience | 33 Years |
Location | 5700 Monroe St, Sylvania, Ohio |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1831198621 | NPI | - | NPPES |
01956 | Other | OH | PARAMOUNT |
000000188006 | Other | OH | ANTHEM |
0137382 | Medicaid | OH | |
07-01505 | Other | OH | UHC |
4604033 | Other | OH | AETNA |
2029049 | Medicaid | OH | |
160051808 | Other | OH | RRMC |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | 35063744 (Ohio) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Promedica Toledo Hospital | Toledo, OH | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Promedica Central Physicians | 2365348190 | 818 |
News Archive
In Oxfordshire,England, for the first time anywhere in the world, there is reliable evidence of a fall in the incidence and severity of stroke in recent years, Oxford University researchers reported in The Lancet this week.
Patients with HIV are significantly more likely to have bipolar disorder than the general population, researchers report.
Nuevolution A/S today announced that it has received a milestone payment derived from its collaboration with Merck & Co. Inc., Whitehouse Station, NJ.
Dr. Anthony Tolcher, clinical director for South Texas Accelerated Research Therapeutics (START) at the START Center for Cancer Care in San Antonio, announced today that the first patient has been enrolled in a groundbreaking Phase I clinical trial of a novel combination anticancer regimen composed of two investigational compounds: MK-2206 from Merck & Co., Inc. and AZD6244 (ARRY-886*) from AstraZeneca.
Today, at the American Diabetes Association's 78th Scientific Sessions in Orlando, Florida, Ascensia Diabetes Care has revealed that UK-based Whisk have been selected as the winner of the Ascensia Diabetes Challenge, a global innovation competition that set out to find digital solutions to support type 2 diabetes management.
› Verified 9 days ago
Entity Name | Promedica Central Physicians |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1043270150 PECOS PAC ID: 2365348190 Enrollment ID: O20031211000226 |
News Archive
In Oxfordshire,England, for the first time anywhere in the world, there is reliable evidence of a fall in the incidence and severity of stroke in recent years, Oxford University researchers reported in The Lancet this week.
Patients with HIV are significantly more likely to have bipolar disorder than the general population, researchers report.
Nuevolution A/S today announced that it has received a milestone payment derived from its collaboration with Merck & Co. Inc., Whitehouse Station, NJ.
Dr. Anthony Tolcher, clinical director for South Texas Accelerated Research Therapeutics (START) at the START Center for Cancer Care in San Antonio, announced today that the first patient has been enrolled in a groundbreaking Phase I clinical trial of a novel combination anticancer regimen composed of two investigational compounds: MK-2206 from Merck & Co., Inc. and AZD6244 (ARRY-886*) from AstraZeneca.
Today, at the American Diabetes Association's 78th Scientific Sessions in Orlando, Florida, Ascensia Diabetes Care has revealed that UK-based Whisk have been selected as the winner of the Ascensia Diabetes Challenge, a global innovation competition that set out to find digital solutions to support type 2 diabetes management.
› Verified 9 days ago
Entity Name | The Toledo Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1407854771 PECOS PAC ID: 2961309638 Enrollment ID: O20031218001042 |
News Archive
In Oxfordshire,England, for the first time anywhere in the world, there is reliable evidence of a fall in the incidence and severity of stroke in recent years, Oxford University researchers reported in The Lancet this week.
Patients with HIV are significantly more likely to have bipolar disorder than the general population, researchers report.
Nuevolution A/S today announced that it has received a milestone payment derived from its collaboration with Merck & Co. Inc., Whitehouse Station, NJ.
Dr. Anthony Tolcher, clinical director for South Texas Accelerated Research Therapeutics (START) at the START Center for Cancer Care in San Antonio, announced today that the first patient has been enrolled in a groundbreaking Phase I clinical trial of a novel combination anticancer regimen composed of two investigational compounds: MK-2206 from Merck & Co., Inc. and AZD6244 (ARRY-886*) from AstraZeneca.
Today, at the American Diabetes Association's 78th Scientific Sessions in Orlando, Florida, Ascensia Diabetes Care has revealed that UK-based Whisk have been selected as the winner of the Ascensia Diabetes Challenge, a global innovation competition that set out to find digital solutions to support type 2 diabetes management.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Jeffrey M Judis, MD 1 Seagate, Suite 800, Toledo, OH 43604-1558 Ph: (567) 585-1964 | Jeffrey M Judis, MD 5700 Monroe St, Suite 202, Sylvania, OH 43560-2767 Ph: (419) 473-6622 |
News Archive
In Oxfordshire,England, for the first time anywhere in the world, there is reliable evidence of a fall in the incidence and severity of stroke in recent years, Oxford University researchers reported in The Lancet this week.
Patients with HIV are significantly more likely to have bipolar disorder than the general population, researchers report.
Nuevolution A/S today announced that it has received a milestone payment derived from its collaboration with Merck & Co. Inc., Whitehouse Station, NJ.
Dr. Anthony Tolcher, clinical director for South Texas Accelerated Research Therapeutics (START) at the START Center for Cancer Care in San Antonio, announced today that the first patient has been enrolled in a groundbreaking Phase I clinical trial of a novel combination anticancer regimen composed of two investigational compounds: MK-2206 from Merck & Co., Inc. and AZD6244 (ARRY-886*) from AstraZeneca.
Today, at the American Diabetes Association's 78th Scientific Sessions in Orlando, Florida, Ascensia Diabetes Care has revealed that UK-based Whisk have been selected as the winner of the Ascensia Diabetes Challenge, a global innovation competition that set out to find digital solutions to support type 2 diabetes management.
› Verified 9 days ago
Jessica Abbate Burns, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5308 Harroun Rd Ste 160, Sylvania, OH 43560 Phone: 419-824-5668 Fax: 419-885-6919 | |
Alma Lydia Garlo, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 5300 Harroun Rd, Suite 119, Sylvania, OH 43560 Phone: 419-885-1161 Fax: 419-824-5199 | |
Robert T. Derosa, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5700 Monroe St, Suite 202, Sylvania, OH 43560 Phone: 419-473-6622 Fax: 419-473-6627 | |
Dr. Burton S Brodsky, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5308 Harroun Rd Ste 175, Sylvania, OH 43560 Phone: 419-824-5608 Fax: 419-882-3686 | |
Robert Drenchko, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5700 Monroe Street, Graduate Medical Education, Sylvania, OH 43560 Phone: 419-473-6622 Fax: 419-473-6627 | |
Terry M Gibbs, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5308 Harroun Rd, Ste 175, Sylvania, OH 43560 Phone: 419-824-5608 Fax: 419-882-3686 | |
Heather Nicole Wahl, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5308 Harroun Rd Ste 165, Sylvania, OH 43560 Phone: 419-824-5608 Fax: 419-882-3686 |